BRKR
NASDAQ
US
Bruker Corporation - Common Stock
$36.76
▲ +$0.68
(+1.88%)
Vol 1.5M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$7.2B
ROE
-1.1%
Margin
-0.6%
D/E
82.59
Beta
1.17
Div Yield
0.42%
52W
$29–$65
Wall Street Consensus
22 analysts · Apr 20267
Strong Buy
8
Buy
6
Hold
1
Sell
0
Strong Sell
68.2%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.66 | $0.59 | $-0.07 |
| Sep 2025 | $0.34 | $0.45 | +$0.11 |
| Jun 2025 | $0.43 | $0.32 | $-0.11 |
| Mar 2025 | $0.44 | $0.47 | +$0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $979.6M | $801.4M | $797.4M | $860.5M | $977.2M |
| Net Income | — | $13.7M | $17.4M | $7.6M | -$59.6M | $26.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 4.4% | 4.4% | 4.4% | 4.4% | -1.1% | -1.1% |
| P/E (TTM) | 78.43 | 64.97 | 65.26 | 74.22 | — | — |
| Net Margin | 0.9% | 2.3% | 2.3% | 2.3% | -0.6% | -0.6% |
| Gross Margin | 45.4% | 48.5% | 48.5% | 48.5% | 48.0% | 48.0% |
| D/E Ratio | 134.99 | 134.99 | 134.99 | 134.99 | 82.59 | 82.59 |
| Current Ratio | 1.61 | 1.61 | 1.61 | 1.61 | 1.85 | 1.85 |
Key Ratios
ROA (TTM)
-0.3%
P/S (TTM)
2.08
P/B
5.0
EPS (TTM)
$-0.14
CF/Share
$2.86
Rev Growth 3Y
+11.7%
52W High
$64.64
52W Low
$28.53
$28.53
52-Week Range
$64.64
Financial Health
Free Cash Flow
$177.8M
Net Debt
$1.7B
Cash
$298.8M
Total Debt
$2.0B
As of Dec 31, 2025
How does BRKR compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
BRKR valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
2.1
▼
46%
below
peers
(3.8)
vs Peers
vs Industry
Undervalued
P/B ratio
5.0
▲
34%
above
peers
(3.7)
vs Peers
vs Industry
Overvalued
Div yield
0.4%
▼
12%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
BRKR profitability vs Life Sciences Tools & Services peers
ROE
-1.1%
▲
67%
above
peers
(-3.3%)
vs Peers
vs Industry
Below avg
Net margin
-0.6%
▲
94%
above
peers
(-9.4%)
vs Peers
vs Industry
Below avg
Gross margin
48.0%
▲
0%
above
peers
(48.0%)
vs Peers
vs Industry
In line
ROA
-0.3%
▲
87%
above
peers
(-2.6%)
vs Peers
vs Industry
Below avg
BRKR financial health vs Life Sciences Tools & Services peers
D/E ratio
82.6
▲
126%
above
peers
(36.5)
vs Peers
vs Industry
High debt
Current ratio
1.9
▼
45%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▼
17%
below
peers
(1.4)
vs Peers
vs Industry
More volatile
BRKR fundamentals radar
BRKR
Peer median
Industry
BRKR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BRKR vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
MUNCH MARK ROBERT
Officer · Mar 13
2000 shs
MUNCH MARK ROBERT
Officer · Mar 13
2000 shs
ROSENTHAL ROBERT JOHN
Director · Feb 13
4520 shs
PACKER RICHARD A
Director · Feb 13
4520 shs
LINTON WILLIAM A.
Director · Feb 13
4520 shs
ORNELL JOHN A
Director · Feb 13
4520 shs
FRANCIS LAURA A.
Director · Feb 13
4520 shs
PERKINS ADELENE QUIGLEY
Director · Feb 13
4520 shs
ANDERSON BONNIE H
Director · Feb 13
4520 shs
REQUARDT HERMANN FRITZ
Director · Feb 13
4520 shs
Last 90 days
Top Holders
Top 5: 39.98%FMR, LLC
10.01%
$513.5M
Orbis Allan Gray Ltd
9.79%
$502.7M
Blackrock Inc.
7.21%
$370.0M
Vanguard Group Inc
6.74%
$346.0M
Pallas Capital Advisors Llc
6.23%
$319.7M
As of Dec 31, 2025
Dividends
$0.20
/ year
Mar 23, 2026
$0.0500
Dec 08, 2025
$0.0500
Sep 23, 2025
$0.0500
Jun 16, 2025
$0.0500
Mar 17, 2025
$0.0500
Dec 02, 2024
$0.0500
Aug 30, 2024
$0.0500
Jun 03, 2024
$0.0500